Z-2589-2026 Class II Ongoing
FDA device recall Z-2589-2026 was initiated by Medline Industries, LP on Feb 27, 2026 and is designated Class II. Reason for recall: Firm identified unapproved design changes to the products outside of the 510(k) cleared by the FDA. Products not initially reported in RES 98601. The recall status is ongoing. Affected quantity: 113,843 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jul 1, 2026
- Initiation Date
- Feb 27, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 113,843 kits
Product description
Convenience kits containing select SKUs of 10mL Polycarbonate Colored Syringes. KIT NEURO CSTM SAMP0551
Reason for recall
Firm identified unapproved design changes to the products outside of the 510(k) cleared by the FDA. Products not initially reported in RES 98601.
Distribution pattern
US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI, WY and the country of Barbados.
Code information
SAMP0551 UDI-DI 10195327268503 Lots 22JBG593 22JBJ361
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2589-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026